Results 191 to 200 of about 114,995 (356)

Diagnostic Yield of Anti‐Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis

open access: yesEuropean Journal of Neurology, Volume 32, Issue 10, October 2025.
In a retrospective analysis of suspected autoimmune encephalitis (AIE) cases from a prospective cohort including patients with an acute presentation, nine cases of antibody‐positive AIE were identified during hospitalization. Extensive additional anti‐neuronal antibody testing did not yield additional cases of antibody‐positive AIE. ABSTRACT Background
Liora ter Horst   +15 more
wiley   +1 more source

Splenectomy for Acholuric Jaundice [PDF]

open access: bronze, 1914
W. Essex Wynter, John Bland‐Sutton
openalex   +1 more source

Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes

open access: yesInternational Journal of Laboratory Hematology, Volume 47, Issue 5, Page 869-876, October 2025.
ABSTRACT Introduction The majority of patients with essential thrombocythemia (ET) show somatic mutations of JAK2, CALR, or MPL. Around 10% of cases lack these mutations (“triple negative” ET, TN‐ET). Additionally, some patients with bona fide “primary thrombocytosis” (PT) [i.e., high platelet (PLT)‐ count with no apparent underlying causes] do not ...
Valentina Sangiorgio   +8 more
wiley   +1 more source

Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 436-460, September/October 2025.
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki   +6 more
wiley   +1 more source

SPLENECTOMY IN THE ANEMIAS [PDF]

open access: green, 1917
William D. Haggard
openalex   +1 more source

Home - About - Disclaimer - Privacy